2025 News Feed
Monoclonal Antibody Ponsegromab Shown to Reduce Effects of Cancer-Related Wasting Syndrome
Cachexia, also known as wasting syndrome, commonly occurs in patients with certain cancers, leading to dangerous weight loss and functional impairment. Medicinal treatments for this condition are rare, but a recent study demonstrated that the antibody ponsegromab is both safe and effective in treating muscle wasting and weight loss in cancer patients. Pennington Biomedical Research Center was one of more than 70 facilities globally to host the study testing the efficacy of this antibody.
Learn More
Global Launch for Clinical Obesity Definition to be Held Jan. 16, Pennington Biomedical Serving as North American Satellite Hub
The Lancet Commission on Clinical Obesity, a globally representative group of 56 worldwide experts, are publishing the first ever definition of clinical obesity at a launch event on Jan. 16. The event will be teleconferenced to various locations across the globe originating from the Royal College of Physicians in London, with the Pennington Biomedical Research Center serving as the satellite site for North America.
Learn More
LSU and Pennington Biomedical’s Stephania Cormier Serves as Frontiers in Immunology Topic Editor on “How RSV Outsmarts the Host”
LSU and Pennington Biomedical Research Center’s Dr. Stephania Cormier joined colleagues Dr. Lawrence Kauvar of Trellis Bioscience Inc. and Dr. Ralph Tripp of the University of Georgia as topic editors on the Frontiers in Immunology research collaboration, “How RSV Outsmarts the Host,” focusing on challenges surrounding Respiratory Syncytial Virus, or RSV.
Learn More
U.S. News & World Report’s 2025 Best Diets: DASH Diet Recognized as Best Heart-Healthy Diet, Ranks as Second-Best Diet Overall
The Dietary Approaches to Stop Hypertension, or DASH, Diet, developed in part by Pennington Biomedical Research Center scientists, has been recognized as the second-best diet overall and the best heart-healthy diet in the 2025 U.S. News & World Report Best Diets Rankings.
Learn More
Pennington Biomedical Highlights How Cellular Quality Control Contribute to Insulin Resistance Related to Type 2 Diabetes
Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with Type 2 Diabetes, or T2D. The study, titled "Deubiquitinating Enzymes Regulate Skeletal Muscle Mitochondrial Quality Control and Insulin Sensitivity in Patients with Type 2 Diabetes," was recently published in the Journal of Cachexia, Sarcopenia and Muscle.
Learn More
